SLU-PP-332 is a synthetic small molecule classified as a PPARd agonist, available as a lyophilized powder for laboratory research
Avoid exposing to room-temperature for extended durations
Published topical skin studies summarized by Schagen included one month of daily thigh application in 20 women, 12-week facial or eye-cream studies in 71 or 41 women, and a 12-week twice-daily Cu-GHK cream study in 67 women [2]
Cellular analysis of the adipose tissue from HFD mice showed that GPNMB high cells, primarily associated with senescent endothelial cells, are significantly reduced due to the effect of the vaccination
Potential Side Effects (Rare and Mild): Injection site irritation or redness Mild digestive upset Temporary changes in hormone levels Slight water retention Our experienced team monitors your progress closely and adjusts your protocol to ensure safety and effectiveness throughout your treatment
Glutamic acid (Glu, E) MW: 147.13 Da Residue mass: 129.04 Da Negatively charged at physiological pH
